2-(2-((2,6-Dichlorophenyl)amino)-5-hydroxyphenyl)acetic acid, 98.00%, 10mg

4-Fluoro-4'-methoxybiphenyl, 96.0%, 5g

2-Methylisothiazolidine 1,1-dioxide, 95.0%, 250mg

4-(6-p-Tolyl-pyridin-3-yl)-pyrimidin-2-ylamine, 95.0%, 1g

2-(2-cyclopropyl-1H-imidazol-1-yl)acetic acid hydrochloride, 95.0%, 250mg

5-Bromo-4-chloro-3-indolyl-�-D-glucuronic acid - cyclohexylammonium salt, >97%, 250mg

4-(2-methoxyethoxy)piperidine hydrochloride, 95.0%, 1g

4-Fluoro-1H-indole-6-carboxylic acid, 95.0%, 1g

7-Bromo-6-fluoroquinazoline-2,4(1H,3H)-dione, 97%, 1g

Piperazine-2,6-dione, 95.0%, 10g

2,2'-(9,9-Dioctyl-9h-fluorene-2,7-diyl)bis(1,3,2-dioxaborinane), 98%, 250mg

N-Ethyl-2-pyrrolidone, min 98%, for synthesis, 1L, glass packaging

METHANEDISULFONYL DICHLORIDE, 96%, 250mg